Viewing StudyNCT04968002



Ignite Creation Date: 2024-05-06 @ 4:22 PM
Last Modification Date: 2024-10-26 @ 2:09 PM
Study NCT ID: NCT04968002
Status: UNKNOWN
Last Update Posted: 2021-07-20
First Post: 2021-06-24

Brief Title: Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer A Prospective Single Arm Single Center Phase II Clinical Study of Neoadjuvant Therapy
Sponsor: Second Affiliated Hospital School of Medicine Zhejiang University
Organization: Second Affiliated Hospital School of Medicine Zhejiang University

Conditions & Keywords Data

Conditions:
Name
Non-small Cell Lung Cancer
Keywords:
Name View
Pabolizumab View
non-small cell lung cancer View